100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series.

Authors

• Vy, Shi
• K, Tran
• F, Patel
• J, Leventhal
• T, Konia
• Ma, Fung
• R, Wilken
• Ms, Garcia
• Sd, Fitzmaurice
• J, Joo
• Am, Monjazeb
• Ba, Burrall
• B, King
• S, Martinez
• Sd, Christensen
• Emanual Maverakis

Type

Published Article

Journal

Journal of the American Academy of Dermatology

Publisher

Elsevier

Volume

73

Issue

4

Pages

645–645

Identifiers

DOI: 10.1016/j.jaad.2015.06.060

Source

maverakislab-ucdavis dermatology-ucdavis

License

Unknown